What's Happening?
Boulder Care, a virtual substance use disorder (SUD) provider, has been awarded $1.8 million by the National Institutes of Health to design and test care pathways in marginalized settings. The grant, supported by the NIH’s National Institute on Drug Abuse,
aims to address the gaps in opioid use disorder treatment, particularly in underserved areas. Boulder Care plans to focus on community corrections, pregnancy and postpartum care, tribal healthcare systems, and transitions from residential treatment and emergency departments. The initiative will involve providing patients with smartphones preloaded with the Boulder app, cellular service, and Wi-Fi to facilitate virtual care. The study will measure outcomes such as care continuity, retention, and quality of life.
Why It's Important?
This initiative addresses a critical need for improved access to substance use disorder treatment in underserved communities. By leveraging telehealth, Boulder Care aims to bridge the gap in care delivery, particularly for vulnerable populations such as those in correctional facilities and tribal nations. The grant supports the development of tailored care pathways, which could lead to more effective treatment and better health outcomes. The project also highlights the potential of digital health solutions to enhance healthcare accessibility and quality, particularly in complex settings where traditional healthcare delivery may be challenging.
What's Next?
The NIH-funded study will last about two years, during which Boulder Care will work with five sites to implement and evaluate the virtual care pathways. The outcomes of this research could inform future policies and practices in SUD treatment, potentially leading to broader adoption of telehealth solutions in similar settings. The success of this initiative could also encourage further investment in digital health technologies to address other healthcare challenges, particularly in underserved communities.
